Alan F. Denenberg
Lawyers
Filters
Atara Biotherapeutics $175 million common stock and pre-funded warrants offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $175 million SEC-registered common stock and pre-funded warrants…
Uber Technologies $1.15 billion convertible notes offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Uber Technologies, Inc. of $1.15 billion aggregate principal amount of its 0% convertible senior notes…
Juniper Networks $800 million notes offering with concurrent cash tender offers
Davis Polk advised the joint book-running managers in connection with an offering by Juniper Networks, Inc. of $400 million aggregate principal amount of its 1.200% senior notes due…
Ingram Micro $7.2 billion acquisition by Platinum Equity
Davis Polk is advising Ingram Micro Inc. on its $7.2 billion acquisition by Platinum Equity from HNA Technology Co., Ltd, a part of HNA Group. The sale is expected to be completed by the…
Seer $336 million IPO and concurrent private placement
Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 10,592,106 shares of Class A common stock of Seer, Inc. at $19.00 per…
BeiGene $340 million secondary offering
Davis Polk advised the underwriter in connection with the $340 million SEC-registered offering of 1,511,546 American depositary shares of BeiGene, Ltd. by certain existing ADS holders. The…
Maravai LifeSciences Holdings $1.863 billion IPO
Davis Polk advised the representatives of the several underwriters in connection with the initial public offering of 69,000,000 shares of Class A common stock of Maravai LifeSciences…
Berkeley Lights $258 million secondary offering
Davis Polk advised the representatives of the several underwriters in connection with the $258 million SEC-registered offering of 3,000,000 shares of common stock of Berkeley Lights,…
Microchip Technology $1.1 billion convertible notes exchanges
Davis Polk is advising the financial adviser to Microchip Technology Incorporated in connection with Microchip’s privately negotiated exchanges of $90 million aggregate principal amount of…
Olema Pharmaceuticals $240 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $240 million initial public offering of 12,650,000 shares of common stock of Olema Oncology at $19…